NASDAQ:IDXX • US45168D1046
Past quarterly earnings results for IDEXX LABORATORIES INC (IDXX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 3.08 | 2.99 | 3.12% | 17.56% | 1.091B | 1.094B | -0.31% | 14.28% |
| Q3 2025 | 3.40 | 3.19 | 6.47% | 21.43% | 1.105B | 1.094B | 1.03% | 13.29% |
| Q2 2025 | 3.63 | 3.37 | 7.81% | 20.20% | 1.109B | 1.089B | 1.88% | 10.55% |
| Q1 2025 | 2.96 | 2.91 | 1.72% | 5.34% | 998.427M | 1.018B | -1.92% | 3.56% |
| Q4 2024 | 2.62 | 2.45 | 6.89% | 12.93% | 954.288M | 953.69M | 0.06% | 5.84% |
| Q3 2024 | 2.80 | 2.73 | 2.49% | 10.67% | 975.543M | 998.77M | -2.33% | 6.56% |
| Q2 2024 | 3.02 | 2.94 | 2.84% | 13.11% | 1.004B | 1.026B | -2.19% | 6.35% |
| Q1 2024 | 2.81 | 2.73 | 3.10% | 10.20% | 964.095M | 985.45M | -2.17% | 7.10% |
| Q4 2023 | 2.32 | 2.16 | 7.31% | 13.17% | 901.601M | 909.07M | -0.82% | 8.81% |
| Q3 2023 | 2.53 | 2.42 | 4.66% | 17.67% | 915.527M | 944.68M | -3.09% | 8.78% |
| Q2 2023 | 2.67 | 2.52 | 6.07% | 71.15% | 943.63M | 953.11M | -0.99% | 9.65% |
| Q1 2023 | 2.55 | 2.47 | 3.31% | 12.33% | 900.195M | 910.32M | -1.11% | 7.61% |
| Q4 2022 | 2.05 | 1.98 | 3.42% | 8.47% | 828.568M | 837.33M | -1.05% | 3.43% |
| Q3 2022 | 2.15 | 2.08 | 3.32% | 5.91% | 841.661M | 847.39M | -0.68% | 3.85% |
| Q2 2022 | 1.56 | 1.59 | -1.83% | -33.33% | 860.546M | 881.16M | -2.34% | 4.16% |
| Q1 2022 | 2.27 | 2.30 | -1.38% | -3.40% | 836.549M | 856.51M | -2.33% | 7.57% |
| Q4 2021 | 1.89 | 1.74 | 8.44% | -5.97% | 801.09M | 797.47M | 0.45% | 11.12% |
| Q3 2021 | 2.03 | 1.95 | 4.27% | 20.12% | 810.421M | 814.12M | -0.45% | 12.28% |
| Q2 2021 | 2.34 | 2.06 | 13.48% | 36.05% | 826.142M | 802.05M | 3.00% | 29.57% |
| Q1 2021 | 2.35 | 1.75 | 34.30% | 82.17% | 777.707M | 752.13M | 3.40% | 24.17% |
| Q4 2020 | 2.01 | 1.43 | 41.05% | - | 720.938M | 694.65M | 3.78% | - |
| Q3 2020 | 1.69 | 1.46 | 15.76% | - | 721.789M | 685.99M | 5.22% | - |
| Q2 2020 | 1.72 | 1.19 | 44.09% | - | 637.592M | 604.92M | 5.40% | - |
| Q1 2020 | 1.29 | 1.22 | 5.44% | - | 626.336M | 629.76M | -0.54% | - |
Notes
IDEXX LABORATORIES INC (IDXX) last reported earnings on 2/2/2026.
IDEXX LABORATORIES INC (IDXX) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, IDEXX LABORATORIES INC (IDXX) has beaten EPS estimates in 4 out of 4 releases.